Private importing
Shopping Guide
    Request Form     Request Form for Corporate Service

Product Overview/Feature

  • JP


Tsumura Byakokaninjinto [34] : 42 sachets(for two weeks)

Sale Price:US$49.49

Warehouse Japan1
Manufacturer TSUMURA & CO.
JAN Code 4987138803498
GS1 ---
Ingredient Code 5200125
Shipping Schedule 5 to 10 working days after payment


TSUMURA Byakkokaninjinto Extract Granules (hereafter TJ-34) is indicated for the relief of thirst and hot flushes


42 sachets


light grayish brown granules

Active Ingredients

9.0 g (3sachets for 1day)of TSUMURA Byakkokaninjinto extract granules contains 5.0 g of a dried extract of the following mixed crude drugs.JP Gypsum 15.0 gJP Anemarrhena Rhizome 5.0 gJP Glycyrrhiza 2.0 gJP Ginseng 1.5 gBrown Rice 8.0 g(JP: The Japanese Pharmacopoeia)


TJ-34 is indicated for the relief of thirst and hot flushes。


The usual adult dose is 9.0 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted according to the patient's age and body weight, and symptoms.


Careful administration(TJ-34should be administered with care in the following patients.)

(1)Patients with weak gastrointestinal tract [Oral cavity discomfort, anorexia, epigastric distress, soft feces, diarrhea,etc. may occur.]
(2)Patients with greatly declined constitution [Adverse reactions are likely to occur, and the symptoms may be aggravated.

Important Precautions

(1)WhenTJ-34 is used, the patient's “SHO” (constitu-tion/symptoms) should be taken into account. The patient's progress should be carefully monitored, and if no improvement in symptoms/findings is observed, continuous treatment should be avoided.
(2)Since TJ-34 contains Glycyrrhiza, careful attention should be paid to the serum potassium level, blood pressure, etc., and if any abnormality is observed, ad-ministration should be discontinued.
(3)When TJ-34is co-administered with other Kampo-preparations (Japanese traditional herbal medicines), etc., attention should be paid to the duplication of the contained crude drugs.


TJ-34 has not been investigated (drug use investigations, etc.) to determine the incidence of adverse reactions. Therefore, the incidence of adverse reactions is not known.